GUJTHEMPharmaceuticals
Gujarat Themis Biosyn Ltd — PE Ratio & Valuation Analysis
₹226.90
-6.10%
Current P/E92.24xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E98.6x6.5% below avg
⚠️
190.3% Premium to Industry
GUJTHEM P/E 92.24x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹4.48 | ₹442 | 98.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Gujarat Themis Biosyn Ltd Valuation
Gujarat Themis Biosyn Ltd (GUJTHEM) currently trades at 92.24x earnings. The Pharmaceuticals sector average PE is 31.77x. GUJTHEM commands a premium, reflecting high growth expectations. Historically, GUJTHEM has traded at an average PE of 98.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
21.69%
Dividend Yield
0.16%
More on Gujarat Themis Biosyn Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.